研究者
J-GLOBAL ID:201801007147906954   更新日: 2024年01月30日

佐藤 工

Ko Sato
研究分野 (1件): 腫瘍生物学
競争的資金等の研究課題 (2件):
  • 2015 - 2018 BRCA1機能不全とエストロゲンの発癌への影響
  • 2011 - 2013 Plk1過剰発現と抗癌剤感受性
論文 (19件):
  • Michal M Hoppe, Patrick Jaynes, Joanna D Wardyn, Sai Srinivas Upadhyayula, Tuan Zea Tan, Stefanus Lie, Diana G Z Lim, Brendan N K Pang, Sherlly Lim, Joe P S Yeong, et al. Quantitative imaging of RAD51 expression as a marker of platinum resistance in ovarian cancer. EMBO molecular medicine. 2021. e13366
  • Teppei Iwata, Anna S Sedukhina, Manabu Kubota, Shigeko Oonuma, Ichiro Maeda, Miki Yoshiike, Wataru Usuba, Kimino Minagawa, Eleina Hames, Rei Meguro, et al. A new bioinformatics approach identifies overexpression of GRB2 as a poor prognostic biomarker for prostate cancer. Scientific reports. 2021. 11. 1. 5696-5696
  • Keiko Oda-Kawashima, Anna S Sedukhina, Naoki Okamoto, Mariya Lytvyn, Kimino Minagawa, Teppei Iwata, Toshio Kumai, Eri Sato, Eiichi Inada, Ayako Yamaura, et al. NF-kB signaling in cardiomyocytes is inhibited by sevoflurane and promoted by propofol. FEBS open bio. 2020
  • Anna Sedukhina, Ko Sato. Multistep in silico analysis for precision oncology in triple negative breast cancer. CANCER SCIENCE. 2018. 109. 452-452
  • Ko Sato. Two kills with one shot: A biomarker with therapeutic implications in poor prognosis gastric cancers. CANCER RESEARCH. 2017. 77. 22
もっと見る
MISC (35件):
特許 (1件):
学位 (1件):
  • 医学博士 (聖マリアンナ医科大学)
※ J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。 登録・更新については、こちらをご覧ください。

前のページに戻る